Ozagrel tromethamine, compound, preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 徐华
- Publication Date
- 2010-03-03
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a medicine with anti-platelet aggregation effect, in particular to an ozagrel salt, more specifically to ozagrel tromethamine and its composition, and a preparation method of the salt. It belongs to the field of medicinal chemistry and pharmaceutical preparation. Background technique
[0002] Ozagrel is a thromboxane synthase inhibitor, which can specifically inhibit thromboxane synthase, has anti-platelet aggregation and relieves vasospasm, can inhibit cerebral thrombosis and cerebral vasospasm, and can be used in subarachnoid space Improvement of cerebral ischemic symptoms after hemorrhagic surgery.
[0003] Due to the poor water solubility of ozagrel, the injection of ozagrel sodium salt is currently used more clinically, but ozagrel is unstable in aqueous solution and can be isomerized to generate cis-imidazole methyl cinnamon acid, and the long-term placement of the aqueous solution of sodium ozagrel in a glass container...